ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 60 filers reported holding ACCELERON PHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $17,210,000 | +174.3% | 100,000 | +100.0% | 0.21% | +195.8% |
| Q2 2021 | $6,275,000 | -8.2% | 50,000 | -0.8% | 0.07% | -18.2% |
| Q1 2021 | $6,838,000 | +144.3% | 50,423 | -32.8% | 0.09% | +319.0% |
| Q3 2017 | $2,799,000 | +76.8% | 75,000 | +25.0% | 0.02% | +40.0% |
| Q1 2016 | $1,583,000 | +1.7% | 60,000 | -14.3% | 0.02% | -76.6% |
| Q3 2013 | $1,556,000 | – | 70,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
| Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
| Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
| Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
| QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
| Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
| Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |